Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enteroflegin
- Development stage
- Unknown
- Lead developer
- Shedir Pharma
- Administration
- Oral
01
Overview
Enteroflegin is a multicomponent nutraceutical formulation developed by Shedir Pharma, specifically designed for the management of symptomatic uncomplicated diverticular disease (SUDD). The product combines standardized natural active ingredients, including extracts of *Boswellia serrata*, *Curcuma longa* (turmeric), and *Matricaria chamomilla* (chamomile). These botanical components work synergistically to provide anti-inflammatory and antispasmodic effects; *Boswellia* inhibits the 5-lipoxygenase enzyme, *Curcuma* modulates inflammatory mediators like NF-kappaB and COX-2, and *Matricaria* helps alleviate gastrointestinal spasms. Clinical data suggests that Enteroflegin is effective in inducing symptom remission, reducing abdominal pain, and lowering fecal calprotectin levels in patients with SUDD, while also potentially aiding in the prevention of acute diverticulitis.
- Brand names
- Enteroflegin
02
Targets
ALOX5 (Arachidonate 5-lipoxygenase)NF-κBPTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Enteroflegin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enteroflegin.